{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:52:40Z","timestamp":1792036360551,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T00:00:00Z","timestamp":1421280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijrobp.2015.01.009","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T22:02:13Z","timestamp":1428530533000},"page":"11-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":363,"title":["Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1658-8585","authenticated-orcid":false,"given":"Joachim","family":"Yahalom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Illidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2015.01.009_bib1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R","article-title":"The epidemiology of non-hodgkin's lymphoma: Comparison of nodal and extra-nodal sites","volume":"72","author":"Newton","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","article-title":"Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"89","author":"Illidge","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11864-014-0286-4","article-title":"Radiotherapy of follicular lymphoma: Updated role and new rules","volume":"15","author":"Yahalom","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): A randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.6004\/jnccn.2014.0125","article-title":"Non-Hodgkin's lymphomas, version 4.2014","volume":"12","author":"Zelenetz","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib7","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1200\/JCO.2007.15.4773","article-title":"Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity","volume":"26","author":"Hoppe","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1053-4296(96)80017-8","article-title":"Management of relapsed and refractory Hodgkin's disease","volume":"6","author":"Yahalom","year":"1996","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: Field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.canrad.2011.04.003","article-title":"State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report no. 83)","volume":"15","author":"Gregoire","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428194.2014.961014","article-title":"The role of radiation therapy in the management of primary central nervous system lymphoma","author":"Milgrom","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib12","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archneur.62.10.1595","article-title":"Delayed neurotoxicity in primary central nervous system lymphoma","volume":"62","author":"Omuro","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2010.01.066","article-title":"Consolidation radiotherapy in primary central nervous system lymphomas: Impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy","volume":"80","author":"Ferreri","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib14","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2007.12.5062","article-title":"Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma","volume":"25","author":"Shah","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-008-9716-0","article-title":"Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy","volume":"91","author":"Correa","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib16","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","article-title":"Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: Final results and long-term outcome","volume":"31","author":"Morris","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000276986.19602.c1","article-title":"Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma","volume":"69","author":"Hottinger","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1200\/JCO.2005.01.161","article-title":"Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma","volume":"23","author":"Nguyen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib19","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.WNL.0000034256.20173.EA","article-title":"Primary CNS lymphoma: A whole-brain disease?","volume":"59","author":"Lai","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1182\/blood-2011-03-321349","article-title":"How I treat primary CNS lymphoma","volume":"118","author":"Ferreri","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncr.11035","article-title":"Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial-brain irradiation","volume":"97","author":"Shibamoto","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib22","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0161-6420(99)90341-X","article-title":"Intraocular-central nervous system lymphoma: Clinical features, diagnosis, and outcomes","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib23","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1212\/01.wnl.0000327672.04729.8c","article-title":"Primary CNS lymphoma with intraocular involvement: International PCNSL collaborative group report","volume":"71","author":"Grimm","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10428194.2013.819576","article-title":"Primary intraocular lymphoma: Treatment outcomes with ocular radiation therapy alone","volume":"55","author":"Teckie","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib25","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0161-6420(02)01125-9","article-title":"Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement","volume":"109","author":"Smith","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib26","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.ijrobp.2007.12.007","article-title":"Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: Treatment approach and review of published data","volume":"71","author":"Puri","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib28","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: Clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib29","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2004.03.039","article-title":"Orbital lymphoma: Is it necessary to treat the entire orbit?","volume":"60","author":"Pfeffer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2010.09.056","article-title":"Ocular risks from orbital and periorbital radiation therapy: A critical review","volume":"79","author":"Jeganathan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10428194.2012.717279","article-title":"Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma","volume":"54","author":"Tran","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib33","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ijrobp.2011.12.097","article-title":"Risk of radiation retinopathy in patients with orbital and ocular lymphoma","volume":"84","author":"Kaushik","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2005.11.035","article-title":"Orbital marginal zone B-cell lymphoma of MALT: Radiotherapy results and clinical behavior","volume":"65","author":"Suh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib35","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ajcp\/81.6.721","article-title":"Non-Hodgkin's lymphomas of the sinonasal region: Histologic subtypes and their clinicopathologic features","volume":"81","author":"Frierson","year":"1984","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<477::AID-CNCR16>3.0.CO;2-U","article-title":"Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy","volume":"80","author":"Logsdon","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood-2013-10-535021","article-title":"The role of radiotherapy and intrathecal cns prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas","volume":"124","author":"Murawski","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00000421-199206000-00008","article-title":"Primary non-Hodgkin's lymphomas of the paranasal sinuses and nasal cavity: A report of 18 cases with stage Ie disease","volume":"15","author":"Tran","year":"1992","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/hed.1077","article-title":"Localized non-Hodgkin's lymphoma of Waldeyer's ring: Clinical features, management, and prognosis of 130 adult patients","volume":"23","author":"Ezzat","year":"2001","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.coc.0000027588.56104.15","article-title":"Waldeyer's ring lymphomas: Treatment results and prognostic factors","volume":"26","author":"Gurkaynak","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib41","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1002\/cncr.24557","article-title":"Diffuse large B-cell lymphoma: Clinical characterization and prognosis of Waldeyer ring versus lymph node presentation","volume":"115","author":"Qi","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/COC.0b013e318187ddbb","article-title":"Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring","volume":"32","author":"Chang","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib43","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1080\/10428190802493686","article-title":"Non-Hodgkin lymphoma of the Waldeyer's ring: Clinicopathologic and therapeutic issues","volume":"49","author":"Laskar","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-004-0860-0","article-title":"Treatment results of tonsillar lymphoma: A 10-year experience","volume":"84","author":"Mohammadianpanah","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijrobp.2010.09.046","article-title":"Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: A multicenter rare cancer network study","volume":"82","author":"Anacak","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2141.2004.04993.x","article-title":"Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection","volume":"126","author":"Ambrosetti","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib47","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib48","first-page":"2075","article-title":"Primary thyroid lymphoma: The 40 year experience of a UK lymphoma treatment centre","volume":"40","author":"Alzouebi","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/10428194.2013.802317","article-title":"Features and outcomes of diffuse large B-cell lymphoma of the thyroid in a large contemporary cohort","volume":"55","author":"Costa","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib50","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1634\/theoncologist.2013-0036","article-title":"Thyroid lymphoma: Recent advances in diagnosis and optimal management strategies","volume":"18","author":"Walsh","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib51","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: A study of 136 cases from the international peripheral T-cell lymphoma project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib52","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-08-2914","article-title":"Variable clinical presentations of nasal and Waldeyer ring natural killer\/T-cell lymphoma","volume":"15","author":"Li","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib53","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage Ie to IIe, nasal, extranodal NK\/T-cell lymphoma: Consortium for improving survival of lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib54","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","article-title":"Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK\/T-cell lymphoma in children and adolescents","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage ie and iie nasal natural killer\/t-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib56","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1200\/JCO.2000.18.17.3144","article-title":"Treatment for primary CNS lymphoma: The next step","volume":"18","author":"Abrey","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib57","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2011.02.039","article-title":"Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK\/T-cell lymphoma","volume":"82","author":"Wang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib58","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ijrobp.2010.10.040","article-title":"Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK\/T-cell lymphoma","volume":"82","author":"Li","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib59","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: The NK-cell tumor study group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12032-014-0320-1","article-title":"Prophylactic cervical lymph node irradiation provides no benefit for patients of stage Ie extranodal natural killer\/T cell lymphoma, nasal type","volume":"32","author":"Wang","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib61","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1259\/bjr\/83758373","article-title":"A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer\/T-cell lymphoma","volume":"82","author":"Tomita","year":"2009","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib62","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ijrobp.2013.08.040","article-title":"High-dose and extended-field intensity modulated radiation therapy for early-stage NK\/T-cell lymphoma of Waldeyer's ring: Dosimetric analysis and clinical outcome","volume":"87","author":"Bi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib63","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","article-title":"Clinical features and treatment outcome of nasal-type NK\/T-cell lymphoma of Waldeyer ring","volume":"112","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib64","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clbc.2012.07.006","article-title":"Treatment and outcomes of primary breast lymphoma","volume":"12","author":"Caon","year":"2012","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib65","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/annonc\/mdp238","article-title":"Primary follicular and marginal-zone lymphoma of the breast: Clinical features, prognostic factors and outcome: A study by the international extranodal lymphoma study group","volume":"20","author":"Martinelli","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/annonc\/mdm471","article-title":"Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the international extranodal lymphoma study group","volume":"19","author":"Ryan","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib67","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1081\/CNV-120005924","article-title":"Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma","volume":"20","author":"Ahmed","year":"2002","journal-title":"Cancer Invest"},{"issue":"Suppl 3","key":"10.1016\/j.ijrobp.2015.01.009_bib68","doi-asserted-by":"crossref","first-page":"B100","DOI":"10.1007\/PL00022769","article-title":"MALT lymphomas: A radiation oncology viewpoint","volume":"80","author":"Yahalom","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib69","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","article-title":"Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: A retrospective, multi-centre, international extranodal lymphoma study group study","volume":"24","author":"Wirth","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib70","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ijrobp.2004.10.025","article-title":"Radiation treatment planning techniques for lymphoma of the stomach","volume":"62","author":"Della Biancia","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10428194.2012.698390","article-title":"Primary follicular lymphoma of the gastrointestinal tract: Effect of stage, symptoms and treatment choice on outcome","volume":"54","author":"Kiess","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clon.2012.02.005","article-title":"Primary testicular lymphoma","volume":"24","author":"Ahmad","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib73","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood-2013-10-530659","article-title":"Primary testicular lymphoma","volume":"123","author":"Cheah","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib74","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/cncr.21930","article-title":"Primary bone lymphoma: Treatment results and prognostic factors with long-term follow-up of 82 patients","volume":"106","author":"Beal","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib75","first-page":"596","article-title":"Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure","volume":"48","author":"Ng","year":"2007","journal-title":"LeukLymphoma"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clon.2006.10.007","article-title":"Primary bone lymphoma: Treatment and outcome","volume":"19","author":"Ford","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2015.01.009_bib77","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.clon.2012.02.006","article-title":"Primary bone lymphoma","volume":"24","author":"Mikhaeel","year":"2012","journal-title":"Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301615000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T05:17:54Z","timestamp":1691558274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0360301615000504"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.009","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}